Literature DB >> 26544909

Method for Sorting and Pairwise Selection of Nanobodies for the Development of Highly Sensitive Sandwich Immunoassays.

Martín A Rossotti1, Macarena Pirez1, Andres Gonzalez-Techera1, Yongliang Cui2, Candace S Bever2, Kin S S Lee2, Christophe Morisseau2, Carmen Leizagoyen3, Shirley Gee2, Bruce D Hammock2, Gualberto González-Sapienza1.   

Abstract

Single domain heavychain binders (nanobodies) obtained from camelid antibody libraries hold a great promise for immunoassay development. However, there is no simple method to select the most valuable nanobodies from the crowd of positive clones obtained after the initial screening. In this paper, we describe a novel nanobody-based platform that allows comparison of the reactivity of hundreds of clones with the labeled antigen, and identifies the best nanobody pairs for two-site immunoassay development. The output clones are biotinylated in vivo in 96-well culture blocks and then used to saturate the biotin binding capacity of avidin coated wells. This standardizes the amount of captured antibody allowing their sorting by ranking their reactivity with the labeled antigen. Using human soluble epoxide hydrolase (sEH) as a model antigen, we were able to classify 96 clones in four families and confirm this classification by sequencing. This provided a criterion to select a restricted panel of five capturing antibodies and to test each of them against the rest of the 96 clones. The method constitutes a powerful tool for epitope binning, and in our case allowed development of a sandwich ELISA for sEH with a detection limit of 63 pg/mL and four log dynamic range, which performed with excellent recovery in different tissue extracts. This strategy provides a systematic way to test nanobody pairwise combinations and would have a broad utility for the development of highly sensitive sandwich immunoassays.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26544909      PMCID: PMC4666776          DOI: 10.1021/acs.analchem.5b03561

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


  33 in total

1.  Multiplexed fluid array screening of phage displayed anti-ricin single domain antibodies for rapid assessment of specificity.

Authors:  George P Anderson; Russell Matney; Jinny L Liu; Andrew Hayhurst; Ellen R Goldman
Journal:  Biotechniques       Date:  2007-12       Impact factor: 1.993

2.  Competitive selection from single domain antibody libraries allows isolation of high-affinity antihapten antibodies that are not favored in the llama immune response.

Authors:  Sofia Tabares-da Rosa; Martin Rossotti; Carmen Carleiza; Federico Carrión; Otto Pritsch; Ki Chang Ahn; Jerold A Last; Bruce D Hammock; Gualberto González-Sapienza
Journal:  Anal Chem       Date:  2011-08-29       Impact factor: 6.986

Review 3.  Nanobodies: natural single-domain antibodies.

Authors:  Serge Muyldermans
Journal:  Annu Rev Biochem       Date:  2013-03-13       Impact factor: 23.643

4.  Isolation and characterization of a thermally stable recombinant anti-caffeine heavy-chain antibody fragment.

Authors:  Ruth C Ladenson; Dan L Crimmins; Yvonne Landt; Jack H Ladenson
Journal:  Anal Chem       Date:  2006-07-01       Impact factor: 6.986

5.  Naturally occurring monoepoxides of eicosapentaenoic acid and docosahexaenoic acid are bioactive antihyperalgesic lipids.

Authors:  Christophe Morisseau; Bora Inceoglu; Kara Schmelzer; Hsing-Ju Tsai; Steven L Jinks; Christine M Hegedus; Bruce D Hammock
Journal:  J Lipid Res       Date:  2010-07-27       Impact factor: 5.922

6.  Hydrolysis of cis- and trans-epoxyeicosatrienoic acids by rat red blood cells.

Authors:  Houli Jiang; Angela G Zhu; Magdalena Mamczur; Christophe Morisseau; Bruce D Hammock; John R Falck; John C McGiff
Journal:  J Pharmacol Exp Ther       Date:  2008-04-29       Impact factor: 4.030

7.  Expression, biotinylation and purification of a biotin-domain peptide from the biotin carboxy carrier protein of Escherichia coli acetyl-CoA carboxylase.

Authors:  A Chapman-Smith; D L Turner; J E Cronan; T W Morris; J C Wallace
Journal:  Biochem J       Date:  1994-09-15       Impact factor: 3.857

Review 8.  Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseases.

Authors:  John D Imig; Bruce D Hammock
Journal:  Nat Rev Drug Discov       Date:  2009-10       Impact factor: 84.694

9.  Hapten mediated display and pairing of recombinant antibodies accelerates assay assembly for biothreat countermeasures.

Authors:  Laura J Sherwood; Andrew Hayhurst
Journal:  Sci Rep       Date:  2012-11-12       Impact factor: 4.379

10.  Bacterial cytoplasm as an effective cell compartment for producing functional VHH-based affinity reagents and Camelidae IgG-like recombinant antibodies.

Authors:  Selma Djender; Aurelie Schneider; Anne Beugnet; Ronan Crepin; Klervi Even Desrumeaux; Chiara Romani; Sandrine Moutel; Franck Perez; Ario de Marco
Journal:  Microb Cell Fact       Date:  2014-09-16       Impact factor: 5.328

View more
  11 in total

1.  Development of Improved Double-Nanobody Sandwich ELISAs for Human Soluble Epoxide Hydrolase Detection in Peripheral Blood Mononuclear Cells of Diabetic Patients and the Prefrontal Cortex of Multiple Sclerosis Patients.

Authors:  Dongyang Li; Christophe Morisseau; Cindy B McReynolds; Thomas Duflot; Jérémy Bellien; Rashed M Nagra; Ameer Y Taha; Bruce D Hammock
Journal:  Anal Chem       Date:  2020-04-27       Impact factor: 6.986

2.  Nanobody Based Immunoassay for Human Soluble Epoxide Hydrolase Detection Using Polymeric Horseradish Peroxidase (PolyHRP) for Signal Enhancement: The Rediscovery of PolyHRP?

Authors:  Dongyang Li; Yongliang Cui; Christophe Morisseau; Shirley J Gee; Candace S Bever; Xiangjiang Liu; Jian Wu; Bruce D Hammock; Yibin Ying
Journal:  Anal Chem       Date:  2017-05-10       Impact factor: 6.986

3.  Generation of Thermally Stable Affinity Pairs for Sensitive, Specific Immunoassays.

Authors:  Elliot Corless; Yining Hao; Huan Jia; Patthara Kongsuphol; Dousabel M Y Tay; Say Yong Ng; Hadley D Sikes
Journal:  Methods Mol Biol       Date:  2022

4.  Nanobody-based label-free photoelectrochemical immunoassay for highly sensitive detection of SARS-CoV-2 spike protein.

Authors:  Yun Chen; Wei Duan; Li Xu; Guanghui Li; Yakun Wan; Henan Li
Journal:  Anal Chim Acta       Date:  2022-05-03       Impact factor: 6.911

5.  Nanobody-based binding assay for the discovery of potent inhibitors of CFTR inhibitory factor (Cif).

Authors:  Natalia Vasylieva; Seiya Kitamura; Jiexian Dong; Bogdan Barnych; Kelli L Hvorecny; Dean R Madden; Shirley J Gee; Dennis W Wolan; Christophe Morisseau; Bruce D Hammock
Journal:  Anal Chim Acta       Date:  2019-01-09       Impact factor: 6.558

Review 6.  VHH antibodies: emerging reagents for the analysis of environmental chemicals.

Authors:  Candace S Bever; Jie-Xian Dong; Natalia Vasylieva; Bogdan Barnych; Yongliang Cui; Zhen-Lin Xu; Bruce D Hammock; Shirley J Gee
Journal:  Anal Bioanal Chem       Date:  2016-05-21       Impact factor: 4.142

Review 7.  Single-Domain Antibodies As Versatile Affinity Reagents for Analytical and Diagnostic Applications.

Authors:  Gualberto Gonzalez-Sapienza; Martín A Rossotti; Sofía Tabares-da Rosa
Journal:  Front Immunol       Date:  2017-08-21       Impact factor: 7.561

8.  Development of a Simple Pretreatment Immunoassay Based on an Organic Solvent-Tolerant Nanobody for the Detection of Carbofuran in Vegetable and Fruit Samples.

Authors:  Jin-Ru Zhang; Yu Wang; Jie-Xian Dong; Jin-Yi Yang; Yu-Qi Zhang; Feng Wang; Rui Si; Zhen-Lin Xu; Hong Wang; Zhi-Li Xiao; Yu-Dong Shen
Journal:  Biomolecules       Date:  2019-10-07

9.  Highly Sensitive Detection of Zika Virus Nonstructural Protein 1 in Serum Samples by a Two-Site Nanobody ELISA.

Authors:  Triana Delfin-Riela; Martín Rossotti; Romina Alvez-Rosado; Carmen Leizagoyen; Gualberto González-Sapienza
Journal:  Biomolecules       Date:  2020-12-09

Review 10.  A guide to: generation and design of nanobodies.

Authors:  Serge Muyldermans
Journal:  FEBS J       Date:  2020-08-28       Impact factor: 5.542

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.